Tremelimumab
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.
Product Specifications
CAS Number
745013-59-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RR214474L4V 200 µL
Olr454 (NM_001000290) Rat Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS2109494-01 0.1 mL
Botin-Linked Monoclonal Antibody to Neurotrophic Tyrosine Kinase Receptor Type 1 (NTRK1)
Sign In for Pricing
View Details MBS2109494-02 0.2 mL
Botin-Linked Monoclonal Antibody to Neurotrophic Tyrosine Kinase Receptor Type 1 (NTRK1)
Sign In for Pricing
View Details MBS2109494-03 0.5 mL
Botin-Linked Monoclonal Antibody to Neurotrophic Tyrosine Kinase Receptor Type 1 (NTRK1)
Sign In for Pricing
View Details